ArticleBMC cancer2014

P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer.

Sung Hoon Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.